Product Images Duloxetine Delayed-release
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Duloxetine Delayed-release NDC 50090-2226 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - duloxetine 01
Figure 1 - duloxetine 02
The graph shows the proportion of patients who experienced a relapse over time after being randomized into either a placebo or duloxetine delayed-release capsule treatment group. The X-axis represents time in days, while the Y-axis shows the percentage of patients with relapse. The duloxetine delayed-release capsule group experienced a lower proportion of relapses compared to the placebo group.*
Figure 2 - duloxetine 03
This is a graph representing the proportion of patients with relapse after treatment with a placebo and Duloxetine delayed-release capsules. The X-axis shows the time in days from randomization to relapse while the Y-axis represents the proportion of patients with relapse. The graph displays two lines representing treatment with a placebo and Duloxetine delayed-release capsules respectively.*
Figure 3 - duloxetine 04
Figure 4 - duloxetine 05
Figure 7 - duloxetine 06
Figure 8 - duloxetine 07
Figure 9 - duloxetine 08
This text displays the percentage of patients improved using placebo and DUL (to treat pain). The numbers represent the percentage of patients who saw improvement (on the left-hand side) while the bottom row (from 0-100) represents the percentage improvement in pain from baseline. It is unclear what the numbers in between represent.*
duloxetine 09
The text appears to be a chart showing the percentage of patients improved from a placebo to a medication called DUL, at a dose of 60mg taken daily. The numbers listed under "percentage of patients improved" are all 8 except for the last one, which is 100. There is also a chart showing percent improvement in pain from baseline. Not enough information is provided to determine what the study was measuring or what condition the medication was intended to treat.*
duloxetine 10
This is a chart that displays the percentage of patients who have improved after taking either a placebo or DUL60/120 mg once daily medication. The x-axis displays the percentage in increments of 10 from 0 to 100, while the y-axis shows the percentage improvement in pain from baseline.*
lbl500902226
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.